i2e Consulting returned with the second edition of Elevate in 2026, bringing together a select group of senior R&D leaders and portfolio executives in an invite-only forum in New York City, focused on pharma R&D portfolios through meaningful peer discussions, practical insights, and actionable takeaways – with thoughtful attention to AI’s growing role in portfolio decision-making.
From expert perspectives to candid hallway conversations, Elevate started meaningful dialogues shaping the future of pharma R&D decision making – prioritization, resource allocation, governance, AI’s role in portfolio intelligence, and more.
Elevate 2026 carried the dialogue forward with stronger insights into portfolio innovation and leadership alignment. Would you like to be part of what comes next?
By submitting this form, you agree to our Terms of Use and Privacy Policy. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about i2e Consulting and our services.